Related Experiment Video
Updated: Jul 8, 2026

13:27
Generation of Human CD40-activated B cells
Published on: October 16, 2009
Conditional immortalization of human B cells by CD40 ligation
Martina Wiesner1, Caroline Zentz, Christine Mayr
1Clinical Cooperative Group Molecular Oncology, GSF - National Research Center, Ludwig-Maximilians-Universität, Munich, Germany.
Plos One
|January 24, 2008
Summary
Human B cells can be conditionally immortalized in vitro without genetic modification. External stimulation alone enables long-term proliferation, offering a new tool for immunotherapy and B cell research.
Area of Science:
- Cell Biology
- Immunology
- Cancer Research
Background:
- Differentiated human cells typically have limited lifespans and proliferation capacities.
- Genetic modification is usually considered necessary for in vitro cell immortalization.
Purpose of the Study:
- To investigate the long-term proliferation potential of human B cells in vitro.
- To determine if external stimulation alone can lead to B cell immortalization.
Main Methods:
- Human B cells from peripheral blood were stimulated via CD40 in the presence of interleukin-4.
- Culture conditions, including cell number and size, were modified.
- Proliferation capacity, phenotype, viral status, and functional responses were assessed over 1650 days.
Main Results:
- CD40 stimulation induced sustained B cell proliferation for over 1650 days (370+ population doublings), suggesting in vitro immortalization.
- These conditionally immortalized B cells maintained a constant phenotype, were Epstein-Barr virus-free, and remained CD40-dependent.
- Cells exhibited constitutive telomerase activity, stabilized telomere length, and responded to Toll-like receptor 9 ligands.
Conclusions:
- Human somatic cells, specifically B cells, can evade senescence and achieve conditional immortalization solely through external stimulation.
- This process does not require genetic manipulation or oncoviral infection.
- Conditionally immortalized human B cells represent a valuable tool for immunotherapy and research into B cell biology and oncogenesis.

